Molecular Templates Inc (NASDAQ:MTEM) shares, rose in value on Thursday, November 21, with the stock price down by -2.06% to the previous day’s close as strong demand from buyers drove the stock to $0.38.
Actively observing the price movement in the last trading, the stock closed the session at $0.39, falling within a range of $0.361 and $0.4. The value of beta (5-year monthly) was 1.219. Referring to stock’s 52-week performance, its high was $5.37, and the low was $0.29. On the whole, MTEM has fluctuated by -43.10% over the past month.
With the market capitalization of Molecular Templates Inc currently standing at about $2.50 million, investors are eagerly awaiting this quarter’s results, scheduled for in December.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MTEM’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of MTEM currently trading nearly -12.19% and -55.72% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.91, while the 7-day volatility ratio is showing 22.80% which for the 30-day chart, stands at 23.12%. Furthermore, Molecular Templates Inc (MTEM)’s beta value is 1.12, and its average true range (ATR) is 0.13.
A comparison of Molecular Templates Inc (MTEM) with its peers suggests the former has fared considerably weaker in the market. MTEM showed an intraday change of -2.06% in last session, and over the past year, it shrunk by -92.32%%.
Data on historical trading for Molecular Templates Inc (NASDAQ:MTEM) indicates that the trading volumes over the past 10 days have averaged 35.36 and over the past 3 months, they’ve averaged 9.62 million. According to company’s latest data on outstanding shares, there are 6.58 million shares outstanding.
Nearly 17.39% of Molecular Templates Inc’s shares belong to company insiders and institutional investors own 41.02% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.27 million shares as on 2024-10-31, resulting in a short ratio of 0.02. According to the data, the short interest in Molecular Templates Inc (MTEM) stood at 585.00 of shares outstanding as of 2024-10-31; the number of short shares registered in 2024-09-30 reached 0.14 million. The stock has fallen by -89.81% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MTEM stock heading into the next quarter.
